Novadigm Consulting GroupManaging Director
Jan. 2011Washington D.C. Metro AreaProviding a broad set of services to pharmaceutical and biotechnology companies, including drug design, pre-clinical and clinical development, biologics manufacturing, business development and corporate development (deal scouting, due diligence, execution and M&A), new product launches, strategic planning and financing (VC and IPO). Member of the Umbrex consultant network. Uniquely broad and deep research and business experience. Managed AAV and adeno virus gene therapy and RNA interference therapeutics programs, including discovery (target selection, constructs design and vectors selection), pre-clinical development (program design, vendor selection etc), IND filings, clinical trial design and management, manufacturing (set up and managed pilot and large scale clinical supply manufacturing), as well as business development and M&A. Deep experiencing in biologics manufacturing.